Companies /Healthcare

Immunome Inc

NASDAQ: IMNM Biotechnology
$20.91
▼ $0.60 (−2.80%) today
Markets open · 3:37pm ET

Fundamentals

Market Cap
$2.4B
EPS (TTM)
$-2.49
52-Week Range
$12 – $30
Street Target
$36.00

About Immunome

Immunome Inc is a biotechnology firm based in Exton, Pennsylvania, focusing on creating innovative cancer treatments. With a rich portfolio that includes immunotherapies, targeted effectors, radioligand therapies, and antibody drug conjugates (ADCs), the company stands at the forefront of cancer research. Immunome is also known for its cutting-edge memory B cell hybridoma technology, which allows for the rapid screening of novel antibodies and targets, marking a significant stride in the fight against cancer since its inception in 2006.

IMNM Coverage